Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley ...

Walmsley said Mackay has "played a very significant role to help deliver the reshaping of GSK and to improve our operating and financial performance," and welcomed the new CFO, highlighting Brown ...

But Sky News reports that shareholders want the incoming CEO to have a reduced pay package compared with her predecessor. Previously head of GSK’s consumer ... at pace with new scientific ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

The investor, who declined to be identified, pointed to Astra’s steadier flow of new products. Philip Hampton, GSK’s chairman ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

In collaboration with GlaxoSmithKline (NYSE:GSK), CureVac reported encouraging ... As CureVac N.V. (NASDAQ:CVAC) welcomes Axel Sven Malkomes as its new CFO, investors might be curious about the ...

Quarterly sales of GSK's RSV vaccine dropped more than 70%, following narrower recommendations for who should get the shot.

GSK said it acquired an experimental therapy from Chimagen Biosciences that it aims to test in different forms of lupus, and ...

In collaboration with GlaxoSmithKline (NYSE ... As CureVac N.V. (NASDAQ:CVAC) welcomes Axel Sven Malkomes as its new CFO, investors might be curious about the company's financial health and ...